NCT06024850 Predictive Factors of Good Results After Multiligamentar Knee Reconstruction (MLKR)
| NCT ID | NCT06024850 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Centre Hospitalier Universitaire de Saint Etienne |
| Condition | Knee Ligament Injury |
| Study Type | OBSERVATIONAL |
| Enrollment | 80 participants |
| Start Date | 2022-02-01 |
| Primary Completion | 2025-03 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 80 participants in total. It began in 2022-02-01 with a primary completion date of 2025-03.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Multiligamentar knee injury has consequences on knee function (instability, arthritis, life disagreement). Surgical reconstructions have known recent evolutions. The goal of this study is to evaluate functional and clinical results at one year of those new surgical technics. A clinical and functional follow up will be performed before the surgery, then at 6 months and one year.
Eligibility Criteria
Inclusion Criteria: * Any patient who benefits of a multiligamentar knee reconstruction at hospital of Saint-Etienne Exclusion Criteria: * Refusal
Contact & Investigator
Thomas NERI, MD PhD
PRINCIPAL INVESTIGATOR
Centre Hospitalier Universitaire de Saint Etienne
Frequently Asked Questions
Who can join the NCT06024850 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Knee Ligament Injury. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06024850 currently recruiting?
Yes, NCT06024850 is actively recruiting participants. Contact the research team at Thomas.Neri@chu-st-etienne.fr for enrollment information.
Where is the NCT06024850 trial being conducted?
This trial is being conducted at Saint-Etienne, France.
Who is sponsoring the NCT06024850 clinical trial?
NCT06024850 is sponsored by Centre Hospitalier Universitaire de Saint Etienne. The principal investigator is Thomas NERI, MD PhD at Centre Hospitalier Universitaire de Saint Etienne. The trial plans to enroll 80 participants.